Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv source : Www.globenewswire.com save search
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
presentation meeting
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 0.82%
H: 3.88%
C: 2.45%
chs-1000 preclinical for meeting
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NXGL | $2.22 0.91% 0.9% 5.6K
|
Manufacturing
|
| O: 1.83%
H: 0.0%
C: -19.42%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.12%
H: 0.01%
C: -0.62%
year revenue
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
Published: 2024-03-25 (Crawled : 12:30) - globenewswire.com
LABP | $22.21 0.27% 0.27% 9.1K
|
|
| O: 176.76%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.19%
H: 0.11%
C: -0.26%
abbvie acquire
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
Published: 2024-03-13 (Crawled : 20:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: -8.7%
H: 21.43%
C: 3.33%
business year update financial
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
Published: 2024-02-27 (Crawled : 01:00) - globenewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: -0.28%
H: 1.46%
C: 1.46%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -1.6%
H: 1.11%
C: 0.41%
epkinly fda license review application
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
| Email alert
Add to watchlist
GNMSF | News | $290.34 3.83% 340
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
cd20 duobody antibody
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
NXGL | $2.22 0.91% 0.9% 5.6K
|
Manufacturing
|
| O: 7.39%
H: 1.06%
C: -5.29%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
revenue
Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: 0.39%
H: 4.92%
C: 1.52%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: 0.24%
H: 3.44%
C: 2.07%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.35%
H: 3.09%
C: 3.03%
financial results
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: -22.6%
H: 3.28%
C: -9.85%
business financial results
NEXGEL Secures Supply Agreement with AbbVie
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
NXGL | $2.22 0.91% 0.9% 5.6K
|
Manufacturing
|
| O: 5.0%
H: 12.49%
C: -4.76%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
abbvie agreement
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
Published: 2023-09-07 (Crawled : 11:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.13%
H: 1.95%
C: 1.89%
ALEC | $5.27 -1.31% -1.33% 380K
|
Health Technology
|
| O: -1.24%
H: 10.79%
C: 8.09%
al002 disease alzheimer’s trial
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
|
| O: 0.21%
H: 3.28%
C: 1.54%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -1.03%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: 1.24%
H: 1.23%
C: 0.88%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.13%
H: 0.3%
C: -0.73%
six business update financial results
Sight Sciences Reports Second Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023
Published: 2023-08-03 (Crawled : 20:00) - globenewswire.com
SGHT | $5.64 0.0% 85K
|
|
| O: 0.62%
H: 10.26%
C: 6.92%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.05%
H: 1.07%
C: -0.83%
year sciences financial results
Genmab Announces Financial Results for the First Half of 2023
Published: 2023-08-03 (Crawled : 15:00) - globenewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: 0.24%
H: 1.29%
C: 1.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -2.25%
H: 1.87%
C: 1.52%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.25%
H: 3.13%
C: 1.84%
financial results
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: 3.49%
H: 14.13%
C: 10.87%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 9.45%
H: 10.53%
C: 7.58%
business financial results
Invivyd Announces Appointment of Sara Cotter to Board Of Directors
Published: 2023-07-27 (Crawled : 20:00) - globenewswire.com
IVVD | $2.13 -6.17% -6.57% 390K
|
Manufacturing
|
| O: -0.69%
H: 4.17%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.72%
H: 1.23%
C: 0.62%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -1.09%
H: 0.3%
C: -0.4%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.